These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 31556110)
1. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients. Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110 [TBL] [Abstract][Full Text] [Related]
2. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822 [TBL] [Abstract][Full Text] [Related]
3. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles. Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760 [TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
6. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
7. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. Zhang J; Chong CC; Chen GG; Lai PB PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780 [TBL] [Abstract][Full Text] [Related]
8. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection. Song SK; Jung WY; Park SK; Chung CW; Park Y PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma. Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802 [No Abstract] [Full Text] [Related]
10. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma. Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353 [TBL] [Abstract][Full Text] [Related]
11. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
12. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion. Chen W; Wang H; Li T; Liu T; Yang W; Jin A; Ding L; Zhang C; Pan B; Guo W; Wang B BMC Med Genomics; 2022 Feb; 15(1):34. PubMed ID: 35197055 [TBL] [Abstract][Full Text] [Related]
13. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153 [TBL] [Abstract][Full Text] [Related]
14. Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma. Zhang X; Zhang D; Bu X; Zhang X; Cui L BMC Bioinformatics; 2022 Nov; 23(1):479. PubMed ID: 36376850 [TBL] [Abstract][Full Text] [Related]
15. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA. Zhang J; Fan J; Zhou C; Qi Y BMC Gastroenterol; 2017 Jun; 17(1):81. PubMed ID: 28637446 [TBL] [Abstract][Full Text] [Related]
16. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
17. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3. Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422 [TBL] [Abstract][Full Text] [Related]
18. miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial. Morkunas E; Vaitkeviciute E; Inciuraite R; Kupcinskas J; Link A; Skieceviciene J; Alunni-Fabbroni M; Schütte K; Malfertheiner P; Varkalaite G; Ricke J Dig Dis; 2024; 42(4):336-348. PubMed ID: 38657585 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
20. Novel miRNA signature for predicting the stage of hepatocellular carcinoma. Yerukala Sathipati S; Ho SY Sci Rep; 2020 Sep; 10(1):14452. PubMed ID: 32879391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]